Evidence map›Paper›PMID 26692284›Full record

ArticleMalaria journal2015

Analysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIX™).

David Koffi, André Offianan Touré, Marie-Louise Varela, Inès Vigan-Womas, Sylvain Béourou, Somela Brou, Marie-France Ehouman, Laeticia Gnamien, Vincent Richard, Joseph Allico Djaman and 1 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. eLife · 2021
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Geospatial joint modeling of vector and parasite serology to microstratify malaria transmission.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. High Prevalence of PolyclonalTropical medicine and infectious disease · 2023
    Article
  9. Article
  10. Review
  11. Diagnostic Methods for Non-Falciparum Malaria.Frontiers in cellular and infection microbiology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Detection of Salmonid IgM Specific to theFrontiers in immunology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

David KoffiUnité de Paludologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire. davidkoffi82@gmail.com.
André Offianan TouréUnité de Paludologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire. andre_offianan@yahoo.fr.
Marie-Louise VarelaUnité d'Immunologie, Institut Pasteur de Dakar, Dakar, Sénégal. lvarela@pasteur.sn.
Inès Vigan-WomasUnité d'Immunologie des Maladies Infectieuses, Institut Pasteur de Madagascar, Antananarivo, Madagascar. ines@pasteur.mg.
Sylvain BéourouUnité de Paludologie, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire. be_sylvain@yahoo.fr.
Somela BrouUFR Biosciences, Université Félix Houphouet Boigny, Abidjan, Côte d'Ivoire. mariejosesomela@yahoo.fr.
Marie-France EhoumanUFR Biosciences, Université Félix Houphouet Boigny, Abidjan, Côte d'Ivoire. emafrancebobin@yahoo.fr.
Laeticia GnamienUFR Biosciences, Université Félix Houphouet Boigny, Abidjan, Côte d'Ivoire. Lae0403gnamien@yahoo.fr.
Vincent RichardUnité d'Epidémiologie, Institut Pasteur de Dakar, Dakar, Sénégal. vrichard@pasteur.sn.
Joseph Allico DjamanUFR Biosciences, Université Félix Houphouet Boigny, Abidjan, Côte d'Ivoire. djamanj@yahoo.fr.
Ronald PerrautUnité d'Immunologie, Institut Pasteur de Dakar, Dakar, Sénégal. perraut@pasteur.sn.
Université Félix Houphouët-Boigny · CIInstitut Pasteur de Côte d'Ivoire · CIInstitut Pasteur de Dakar · SNInstitut Pasteur de Madagascar · MG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvances in malaria control have reduced the burden of disease resulting from exposure to parasite infections. The consequences on naturally acquired immunity are unclear. A magnetic bead-based immunoassay (MBA) to assess antibody levels in populations living in endemic areas was previously evaluated. In this study, the effect of clinical attacks on immunity was analysed in three sentinel sites of Ivory Coast.

methodsRecombinant proteins or peptides derived from liver or blood stage antigens of Plasmodium falciparum (CSP, LSA141, LSA3, SALSA, PF13-DBL1α1, GLURP, AMA1, MSP1p19, MSP4p20), the CSP of Plasmodium malariae and the salivary glands antigen of Anopheles gambiae (gSG6) were covalently linked to a colour-coded microsphere (Luminex™ beads) for the multiplex assay. ELISA was used for whole parasite extract antigen. Blood samples (n = 94) of patients consulting for symptomatic malaria attacks and living in three different malaria endemic settings (rural and periurban) were analysed.

resultsHighly variable seroprevalence of antibody responses against parasite antigens was found ranging from 3 (gSG6) to 97% (MSP4p20). A marked prevalence and significantly higher level of antibodies was found in patients from the rural site (Korhogo), those harbouring the lowest level of parasitaemia. The use of whole schizont extract could not discriminate immunity level, contrary to parasite-derived recombinant proteins or peptides. Prevalence of responders to LSA141 and levels of antibodies to PF13 were significantly different between the three settings. Moreover, the post-treatment clearance of parasites was clearly associated with a significantly higher level of antibody response for almost 50% of the parasite antigens tested.

conclusionThe multiplex MBA-Magpix technology assay provides an accurate high throughput monitoring of parasite-specific antibodies during symptomatic malaria. The levels of antibody responses may provide a risk criterion with respect to the degree of parasitic infection. Additionally, they can be used as an indicator in the implementation of malaria prevention and local control strategies.

Indexed as

AdolescentAdultAgedAnimalsAntibodies, ProtozoanChildChild, PreschoolCote d'IvoireEnzyme-Linked Immunosorbent AssayFemaleFluorescent Antibody TechniqueHumansInfantMalariaMaleMiddle AgedAntibodies, Protozoan

Identifiers

PMID26692284
PMCPMC4687342
OpenAlexW2199987764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.